Drug studies in humans
Last updated: 2021 May 15
Total hit(s): 218
S.No.
1
32621739
Early Combination of Tocilizumab and Corticosteroids: An Upgrade in Anti-inflammatory Therapy for Severe Coronavirus Disease (COVID)
Clin Infect Dis
2021 May 4
7.71
6
2
33871567
SARS-CoV-2 spike therapeutic antibodies in the age of variants
J Exp Med
2021 May 3
10.35
1
3
33753421
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
Gut
2021 May
15.78
7
4
33847768
[Antibody therapy in patients with COVID-19]
Internist (Berl)
2021 May
1
5
33785883
Antibody responses to SARS-CoV-2 infection are attenuated in infliximab-treated patients with IBD
Nat Rev Gastroenterol Hepatol
2021 May
13.15
1
6
33825689
Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis
JMIR Public Health Surveill
2021 Apr 7
Cant find
1
7
33893337
Short term survival of critically ill COVID-19 Egyptian patients on assisted ventilation treated by either Dexamethasone or Tocilizumab
Sci Rep
2021 Apr 23
4.12
1
8
33888152
Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment
Microb Cell Fact
2021 Apr 22
1
9
33863281
Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19
BMC Infect Dis
2021 Apr 16
2.58
1
10
33691139
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
Cell
2021 Apr 1
27.35
21
11
33900819
Antibody Therapy: From Diphtheria to Cancer, COVID-19, and Beyond
Monoclon Antib Immunodiagn Immunother
2021 Apr
1
12
33582019
Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome
Int Immunopharmacol
2021 Apr
3.38
2
13
33743799
Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults
Trials
2021 Mar 20
2
2
14
33802761
Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence
Int J Mol Sci
2021 Mar 17
4.21
2
15
33809772
Multicenter Study of the Seroprevalence of Antibodies against Covid-19 in Patients with Lymphoma: An Analysis of the Oncological Group for the Treatment and Study of Lymphomas (Gotel)
Curr Oncol
2021 Mar 16
2
1
16
33211088
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo
J Exp Med
2021 Mar 1
10.35
5
17
33474735
AAMC Discusses Monoclonal Antibody Therapeutics for SARS-CoV-2 Infection
J Clin Pharmacol
2021 Mar
4.8
1
18
33368305
Simple modifications of therapeutic plasma exchange treatments during the SARS-CoV-2 pandemic
Transfusion
2021 Mar
2.75
1
19
32515023
A call for the appropriate application of clinical pharmacological principles in the search for safe and efficacious COVID-19 (SARS-COV-2) treatments
Br J Clin Pharmacol
2021 Mar
3.98
8
20
32505474
Battle against COVID-19: Efficacy of Convalescent Plasma as an emergency therapy
Am J Emerg Med
2021 Mar
1.68
4
21
33522939
Convalescent plasma therapy for COVID-19 patients: a protocol of a prospective meta-analysis of randomized controlled trials
Trials
2021 Feb 1
2
1
22
32402416
[Intestinal perforation in patient with COVID-19 infection treated with tocilizumab and corticosteroids. Report of a clinical case]
Cir Esp
2021 Feb
0.36
1
23
32860964
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
Clin Microbiol Infect
2021 Feb
6.17
17
24
33560276
Pharmacological treatment during CoViD-19 and mental health issues
Riv Psichiatr
2021 Jan-Feb
1
25
33551490
COVID-19 Convalescent Plasma: from donation to treatment - A Systematic Review & Single Center Experience
Mo Med
2021 Jan-Feb
0.209 (5 year)
1